Freeman Technology relocates to larger premises
New global hq includes manufacturing and office space and an applications laboratory
The new 6,000ft2 global headquarters has been equipped to meet the company’s requirements for manufacturing and office space, as well as housing a 300ft2 applications laboratory.
The move into this ultra-modern facility comes just over a decade after the company launched its first powder testing instrument.
Operations director Tim Freeman said: ‘I am delighted to be able to report that demand for the FT4 powder rheometer continues to grow around the world and across powder processing industries.
‘As a result, not only are we building more systems, but we are also continuing to invest in r&d and applications development.
‘This new facility will enable us to scale up our manufacturing and r&d operations and continue to expand well into the future.’
He said the new laboratory would enable the company to carry out additional in-house research into powder behaviour and processing and provide more extensive applications support for customers.
Freeman Technology has enjoyed a continued period of growth and success. This year the company has not only added to its UK-based team but also expanded its global distribution network, with new partnerships covering Japan, India, Singapore, Malaysia, Thailand and Taiwan.
You may also like
Trending Articles
You may also like
Manufacturing
![SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs]()
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs
Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Portable gas detection in the pharmaceutical sector]()
Portable gas detection in the pharmaceutical sector
Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
![New legal duties for QPs in decentralised manufacturing]()
New legal duties for QPs in decentralised manufacturing
In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Manufacturing
![FDA escalates action against Dabur India over systemic data-integrity and cGMP failures]()
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures
The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Manufacturing
![DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction]()
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction
The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
